NEW HAVEN, Conn., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. Â (NASDAQ: PRPO) has made major strides in cleaning up its balance sheet with two major...
NEW HAVEN, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.  (NASDAQ: PRPO) will be presenting at ASH the findings of a joint study conducted with...
NEW HAVEN, Conn., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Precipio, Inc. reports that the Company recently identified a single, limited scope unauthorized access to a specific data folder stored within its...
NEW HAVEN, Conn., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.  (NASDAQ: PRPO) , filed its 10-Q report today. The following are the highlights of the Company’s...
NEW HAVEN, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. Â (NASDAQ: PRPO) , will be hosting its Q3-2025 corporate update call on November 17 th , 2025...
NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.  (NASDAQ: PRPO) , has terminated its ATM (At-The-Market) instrument with investment bank...
NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.  (NASDAQ: PRPO) , filed its 10-Q report today. The following are the highlights of the...
NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.  (NASDAQ: PRPO) , will be hosting its Q2-2025 corporate update call on August 14 th , 2025...
Arena Group Holdings and Precipio entered Barchart’s Top 100 Stocks to Buy on Monday. Both are up more than 100% in 2025. However, when it comes down to making a bet, the latter is the wiser long-term...